Inventor
WU LIANGXING
US113 patents
Patents
50 patentsUS10308644B2Jun 4, 2019
Heterocyclic compounds as immunomodulators
INCYTE CORP115 citations99
US10669271B2Jun 2, 2020
Heterocyclic compounds as immunomodulators
INCYTE CORP40 citations98
US10251892B2Apr 9, 2019
Bicyclic heterocycles as FGFR4 inhibitors
INCYTE CORP33 citations98
US10214528B2Feb 26, 2019
Bicyclic heterocycles as FGFR4 inhibitors
INCYTE CORP35 citations98
US10131667B2Nov 20, 2018
Substituted tricyclic compounds as FGFR inhibitors
INCYTE CORP35 citations98
US9890156B2Feb 13, 2018
Bicyclic heterocycles as FGFR4 inhibitors
INCYTE CORP40 citations98
US9708318B2Jul 18, 2017
Bicyclic heterocycles as FGFR4 inhibitors
INCYTE CORP44 citations98
US9611267B2Apr 4, 2017
Substituted tricyclic compounds as FGFR inhibitors
INCYTE CORP54 citations98
US9533984B2Jan 3, 2017
Bicyclic heterocycles as FGFR inhibitors
INCYTE CORP42 citations98
US10618916B2Apr 14, 2020
Heterocyclic compounds as immunomodulators
INCYTE CORP31 citations97
US11401279B2Aug 2, 2022
Pyrido[3,2-d]pyrimidine compounds as immunomodulators
INCYTE CORP24 citations95
US11414433B2Aug 16, 2022
Heterocyclic compounds as immunomodulators
INCYTE CORP23 citations94
US11407749B2Aug 9, 2022
Heterocyclic compounds as immunomodulators
INCYTE CORP23 citations94
US11339149B2May 24, 2022
Heterocyclic compounds as immunomodulators
INCYTE CORP24 citations94
US11173162B2Nov 16, 2021
Bicyclic heterocycles as FGFR4 inhibitors
INCYTE CORP22 citations94
US11124511B2Sep 21, 2021
Heterocyclic compounds as immunomodulators
INCYTE CORP28 citations94
US11053246B2Jul 6, 2021
Substituted tricyclic compounds as FGFR inhibitors
INCYTE CORP23 citations94
US11014923B2May 25, 2021
Bicyclic heterocycles as FGFR4 inhibitors
INCYTE CORP22 citations94
US10947230B2Mar 16, 2021
Bicyclic heterocycles as FGFR inhibitors
INCYTE CORP26 citations94
US10906920B2Feb 2, 2021
Heterocyclic compounds as immunomodulators
INCYTE CORP29 citations94
US10851105B2Dec 1, 2020
Bicyclic heterocycles as FGFR4 inhibitors
INCYTE CORP27 citations94
US10800768B2Oct 13, 2020
Heterocyclic compounds as immunomodulators
INCYTE CORP30 citations94
US10793565B2Oct 6, 2020
Heterocyclic compounds as immunomodulators
INCYTE CORP27 citations94
US10738048B2Aug 11, 2020
Bicyclic heterocycles as FGFR4 inhibitors
INCYTE CORP28 citations94
US10632126B2Apr 28, 2020
Bicyclic heterocycles as FGFR4 inhibitors
INCYTE CORP27 citations94
US10174030B2Jan 8, 2019
Cyclopropylamines as LSD1 inhibitors
INCYTE CORP14 citations94
US9994546B2Jun 12, 2018
Cyclopropylamines as LSD1 inhibitors
INCYTE CORP19 citations94
US9944647B2Apr 17, 2018
Heterocyclic compounds as LSD1 inhibitors
INCYTE CORP30 citations94
US9801889B2Oct 31, 2017
Bicyclic heterocycles as FGFR4 inhibitors
INCYTE CORP40 citations94
US9758523B2Sep 12, 2017
Triazolopyridines and triazolopyrazines as LSD1 inhibitors
INCYTE CORP21 citations94
US9695180B2Jul 4, 2017
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
INCYTE CORP24 citations94
US9695168B2Jul 4, 2017
Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
INCYTE CORP27 citations94
US9695167B2Jul 4, 2017
Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors
INCYTE CORP33 citations94
US9670210B2Jun 6, 2017
Cyclopropylamines as LSD1 inhibitors
INCYTE CORP23 citations94
US9580423B2Feb 28, 2017
Bicyclic heterocycles as FGFR4 inhibitors
INCYTE CORP42 citations94
US9527835B2Dec 27, 2016
Cyclopropylamines as LSD1 inhibitors
INCYTE CORP25 citations94
US9493442B2Nov 15, 2016
Cyclopropylamines as LSD1 inhibitors
INCYTE CORP30 citations94
US9493450B2Nov 15, 2016
Cyclopropylamines as LSD1 inhibitors
INCYTE CORP26 citations94
US11840534B2Dec 12, 2023
Substituted tricyclic compounds as FGFR inhibitors
INCYTE CORP4 citations86
US11787793B2Oct 17, 2023
Heterocyclic compounds as immunomodulators
INCYTE CORP9 citations86
US11718605B2Aug 8, 2023
Heterocyclic compounds as immunomodulators
INCYTE CORP11 citations86
US11673883B2Jun 13, 2023
Heterocyclic compounds as immunomodulators
INCYTE CORP12 citations86
US11667635B2Jun 6, 2023
Bicyclic heterocycles as FGFR4 inhibitors
INCYTE CORP7 citations86
US11613536B2Mar 28, 2023
Heterocyclic compounds as immunomodulators
INCYTE CORP15 citations86
US11608337B2Mar 21, 2023
Heterocyclic compounds as immunomodulators
INCYTE CORP15 citations86
US11596692B1Mar 7, 2023
PD-L1/STING conjugates and methods of use
INCYTE CORP12 citations86
US11572366B2Feb 7, 2023
Heterocyclic compounds as immunomodulators
INCYTE CORP15 citations86
US11566026B2Jan 31, 2023
Heterocyclic compounds as immunomodulators
INCYTE CORP16 citations86
US11465981B2Oct 11, 2022
Heterocyclic compounds as immunomodulators
INCYTE CORP18 citations86
US11066404B2Jul 20, 2021
Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
INCYTE CORP13 citations86
Showing the top 50 of 113 patents by PatentIndex Score.